Visiopharm Broaden its Diagnostic Digital Pathology Solution with Oncotopix Scan

November 27th, 2017

Visiopharm has entered an agreement with HAMAMATSU to sell their portfolio of slide scanners, co-branded as Oncotopix® Scan, for clinical customers in Europe.

For many diagnostic pathology labs, implementing Digital Pathology is a major and often disruptive step. They are looking for a partner that can provide complete solutions in a way that is incremental, scalable, cost efficient and risk free in each step.

 Our goal is to assist the customers building a modern and effective diagnostic workplace with new time saving and quality enhancing tools. The Oncotopix® solution is designed to deliver:

  • A functional diagnostic digital pathology solution with cutting edge tools that are easy and cost effective to integrate in existing workflows.
  • Compatibility with all major pathology workflow solutions. Manage patient data and digital whole slides in a secure and effective way from within the LIS/LIMS or PACS system.
  • An open platform enabling the user to add new diagnostic tools as the technology evolves.

Adding a slide scanner to the Oncotopix® solutions is a logical next step to provide a fully functional solution for Visiopharm’s diagnostic customers.

“Over the last 5 years, we have sold and successfully deployed the Hamamatsu Nanozoomer slide scanners in around 30 diagnostic pathology labs in the Nordic countries. These systems are developed to meet the demands of a high through-put laboratory and has proven to be a reliable component in the digital pathology workflow. This has given us a lot of trust in Hamamatsu both as an organization and as a provider of scanning technology for this rapidly evolving diagnostic field.”
Rickard Lindelöf, Sr. VP of Clinical Product Management in Visiopharm.

“Hamamatsu Photonics, a leading manufacturer of Whole Slide Image (WSI) scanners, are delighted with the collaboration with Visiopharm, a digital pathology software and solution integrator.  We are pleased that our renowned range of WSI scanners will form a key part of an integrated digital pathology solution.  We expect this collaboration will contribute to the more rapid use of integrated digital pathology solutions within the European clinical market. Hamamatsu’s collaboration with Visiopharm is one of the steps our Company is taking to increase awareness and acceptance of Digital Pathology.” 
Dr. Peter Eggl, Managing Director, Hamamatsu Photonics Europe


In other words, the complete Onctopix solution offers:

State-of-the-art scanning, slide management, full compatibility with all commercially available slide scanner formats, DICOM compliance, the fastest and most versatile viewer on the market.

The CE-marked image analysis provides precision pathology and high-throughput pathology, by providing: Automated detection of tumor / stromal / Pre-invasive cells, hot-spots, sub-cellular Biomarker quantification, and with the largest library of image analysis APPs available.

If you have any future questions, please do not hesitate to contact us;

Best regards

Rickard Lindelöf,

Sr. VP of Clinical Product Management , Visiopharm

About us:

Visiopharm is a world leader in Augmented Pathology™ solutions, implemented in the Oncotopix® suite of digital pathology software for Hospitals, biopharmaceutical companies and research institutions with over 850 licenses worldwide.

Oncotopix® digital pathology solutions combine precision pathology with high-throughput pathology in a scalable software solution that fits the needs and volumes of any lab, and seamlessly plugs in to laboratory workflows via the IMS, LIS or PACS systems already installed in the lab.

ONCOTOPIX® Diagnostics, a robust solution for cancer diagnostics with CE-IVD algorithms for the breast panel, and VirtualDoubleStaining TM. Our software is featured in over 1150 scientific publications

Hamamatsu Photonics is a world-leading manufacturer of optoelectronic components and systems. The Company’s corporate philosophy stresses the advancement of photonics through extensive research and yields products that are regarded as state-of-the-art. Hamamatsu has a decade of real world experience in delivering sophisticated Whole Slide Imaging (WSI) solutions across the globe. The NanoZoomer slide scanners are designed to meet the needs of digital pathology including archiving, second opinions and automated analysis.